138 related articles for article (PubMed ID: 11904338)
1. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
2. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
3. Btk expression is controlled by Oct and BOB.1/OBF.1.
Brunner C; Wirth T
Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
McCune RC; Syrbu SI; Vasef MA
Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
Pfisterer P; Zwilling S; Hess J; Wirth T
J Biol Chem; 1995 Dec; 270(50):29870-80. PubMed ID: 8530384
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.
Greiner A; Müller KB; Hess J; Pfeffer K; Müller-Hermelink HK; Wirth T
Am J Pathol; 2000 Feb; 156(2):501-7. PubMed ID: 10666379
[TBL] [Abstract][Full Text] [Related]
8. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
Laumen H; Nielsen PJ; Wirth T
Eur J Immunol; 2000 Feb; 30(2):458-69. PubMed ID: 10671201
[TBL] [Abstract][Full Text] [Related]
9. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
[TBL] [Abstract][Full Text] [Related]
10. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
Hess J; Nielsen PJ; Fischer KD; Bujard H; Wirth T
Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
[TBL] [Abstract][Full Text] [Related]
11. Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.
Mueller K; Quandt J; Marienfeld RB; Weihrich P; Fiedler K; Claussnitzer M; Laumen H; Vaeth M; Berberich-Siebelt F; Serfling E; Wirth T; Brunner C
Nucleic Acids Res; 2013 Feb; 41(4):2138-54. PubMed ID: 23293002
[TBL] [Abstract][Full Text] [Related]
12. Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.
Laumen H; Brunner C; Greiner A; Wirth T
Nucleic Acids Res; 2004; 32(4):1577-83. PubMed ID: 15004244
[TBL] [Abstract][Full Text] [Related]
13. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA; Duan H; Garcia PB; Boxer LM
Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
[TBL] [Abstract][Full Text] [Related]
14. [Expression of Oct2 and its significance in lymphoma diagnosis].
Zhao XR; Ma DL
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):337-40. PubMed ID: 16185500
[TBL] [Abstract][Full Text] [Related]
15. BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function.
Betzler AC; Fiedler K; Hoffmann TK; Fehling HJ; Wirth T; Brunner C
Eur J Immunol; 2022 Mar; 52(3):404-417. PubMed ID: 34918350
[TBL] [Abstract][Full Text] [Related]
16. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
18. Regulation of BOB.1/OBF.1 stability by SIAH.
Boehm J; He Y; Greiner A; Staudt L; Wirth T
EMBO J; 2001 Aug; 20(15):4153-62. PubMed ID: 11483518
[TBL] [Abstract][Full Text] [Related]
19. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
Torlakovic E; Tierens A; Dang HD; Delabie J
Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
